p53 and apoptosis

Seminars in Cancer Biology

Volumn 8, Issue 5, 1998, Pages 359-368

  Gottlieb, Tanya M ^a   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; p53; Tumor suppressor

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR;

APOPTOSIS; CARCINOGENESIS; GROWTH INHIBITION; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0031987288     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1998.0098     Document Type: Article

References (122)

1. 1. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352:345-347
2. 2. Oren M (1994) Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol 5:221-227
3. 3. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849
4. 4. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852
5. 5. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 9:1767-1773
6. 6. Gottlieb TM, Oren M (1996) p53 in growth control and neoplasia. Biochim Biophys Acta 1287:77-102
7. 7. Ko LJ, Prives C (1996) p53: puzzle and paradigm. Genes Dev 10:1054-1072
8. 8. Hansen R, Oren M (1997) p53: from inductive signal to cellular effect. Curr Opin Genet Dev 7:46-51
9. 9. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323-331
10. 10. Debbas M, White E (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 7:546-554
11. 11. Wu X, Levine AJ (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91:3602-3606
12. 12. Qin XQ, Livingston DM, Kaelin WJ, Adams PD (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91:10918-10922
13. waf1/cip1. Genes Dev 8:2817-2830
14. 14. Hermeking H, Eick D (1994) Mediation of c-Myc-induced apoptosis by p53. Science 265:2091-2093
15. 15. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88-91
16. 16. Linke SP, Clarkin KC, Leonardo AD, Tsou A, Wahl GM (1996) A reversible G0/G1 arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 10:934-947
17. 17. Yin Y, Terauchi Y, Solomon GG, Aizawa S, Rangarajan PN, Yazaki Y, Kadowaki T, Barrett JC (1998) Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 391:707-710
18. 18. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21 undergo normal development but are defective in G1 checkpoint control. Cell 675-684
19. 19. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557
20. 20. Caelics C, Helmberg A, Karin M (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370:220-223
21. 21. Bissonnette N, Wasylyk B, Hunting DJ (1997) The apoptotic and transcriptional transactivation activities of p53 can be dissociated. Biochem Cell Biol 75:351-358
22. 22. Haupt Y, Rowan S, Shaulian E, Vousden K, Oren M (1995) Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev 9:2170-2183
23. 23. Sabbatini P, Lin J, Levine AJ, White E (1995) Essential role for p53-mediated transactivation in apoptosis but not growth suppression. Genes Dev 9:2184-2192
24. 24. Attardi LD, Lowe SW, Brugarolas J, Jacks T (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene mediated apoptosis. EMBO J 15:3693-3701
25. 25. Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins JR, May E (1996) Transcriptional activation plays a role in the induction of apoptosis by transiently transfected p53. Oncogene 12:2197-2205
26. 26. Ryan KM, Vousden KH (1998) Characterisation of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol 18:3692-3698
27. 27. Gottlieb E, Lindner S, Oren M (1996) Relationship of sequence-specific transactivation and p53 regulated apoptosis in interleukin 3-dependent hematopoietic cells. Cell Growth Diff 7:301-310
28. 28. Kitada S, Krajewski S, Miyashita T, Krajewska M, Reed JC (1996) Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 12:187-192
29. 29. Reinke V, Lozano G (1997) The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. Oncogene 15:1527-1534
30. 30. Resnick-Silverman L, St Clair S, Maurer M, Zhao K, Manfredi JJ (1998) Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev 12:2102-2107
31. 31. Friedlander P, Haupt Y, Prives C, Oren M (1996) A mutant p53 that discriminates between p53 responsive genes cannot induce apoptosis. Mol Cell Biol 16:4961-4971
32. 32. Ludwig RL, Bates S, Vousden KH (1996) Differential transcriptional activation of target cellular promotors by p53 mutants with impaired apoptotic function. Mol Cell Biol 16:4952-4960
33. 33. Wang Y, Prives C (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases Nature 376:88-89
34. 34. Lohrum M, Scheidtmann KH (1996) Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes. Oncogene 13:2527-2539
35. 35. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175-1184
36. 36. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827
37. 37. Lee CW, Sorensen TS, Shikama N, La Thangue N (1998) Functional interplay between p53 and E2F through coactivator p300. Oncogene 16:2695-2710
38. 38. Thomas A, White E (1998) Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev 12:1975-1985
39. 39. Kaghad M (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other cancers. Cell 90:809-819
40. 40. Jost CA, Marin MC, Kaelin W (1997) p73 is a human p53-related protein that can induce apoptosis. Nature 389:191-194
41. 41. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M, Ikawa S (1998) Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 4:839-843
42. 42. Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D (1998) A new human p53 homologue. Nat Med 4:747-778
43. 43. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homologue at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316
44. 44. Canman CE, Kastan MB (1998) Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis. Oncogene 16:957-966
45. 45. Polyak K, Waldman T, He T-C, Kinzler KW, Vogelstein B (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10:1945-1952
46. 46. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299
47. 47. Kelekar A, Thompson CB (1998) Bcl-2-family proteins: the role of the BH3 domains in apoptosis. Trends Cell Biol 8:324-330
48. 48. Knudson CM, Tung KSK, Tourtellote WG, Brown GAJ, Korsmeyer SJ (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96-99
49. 49. McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW (1997) bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci USA 94:2345-2349
50. 50. Yin C, Knudson CM, Korsmeyer SJ, Van DT (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637-640
51. 51. Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA, Morrison RS (1998) Bax involvement in p53-mediated neuronal cell death. J Neurosci 18:1363-1373
52. 52. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305-1308
53. 53. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang W-W, Kruzel E, Radinsky R (1995) Wild-type p53 and a temperature sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15:3032-3040
54. 54. Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedmann SL, Galle PR, Stremmel W, Oren M, Krammer PH (1998) p53 activates the CD95 (APO 1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (in press).
55. 55. Friesen C, Herr I, Krammer PH, Debatin KM (1996) Involvement of the CD95 (APO 1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574-577
56. 56. Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, El-Deiry W (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17:141-143
57. 57. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace AJ, El-Deiry W (1998) p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 58:1593-1598
58. 58. Green D, Kroemer G (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8: 267-271
59. 59. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53 induced apoptosis. Nature 389:300-305
60. 60. Walker KK, Levine AJ (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93:15335-15340
61. 61. Sakamuro D, Sabbatini P, White E, Prendergast GC (1997) The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15:887-898
62. 62. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L (1998) The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J 17:4668-4679
63. 63. Buckbinder LR, Talbott S, Velasco-Miguel I, Takenaka B, Faha B, Seizinger BR, Kley N (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649
64. 64. Rajah R, Valentinis B, Cohen P (1997) Insulin like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53-and IGF-independent mechanism. J Biol Chem 272:12181-12188
65. 65. Prisco M, Kongo A, Rizzo MG, Sacchi A, Baserga R (1997) The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol 17:1084-1092
66. 66. Harrington EA, Bennett MR, Fanidi A, Evan GI (1994) c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295
67. 67. Israeli D, Tessler E, Haupt Y, Elkeles A, Wilder S, Amson R, Telerman A, Oren M (1997) A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J 16:4384-4392
68. 68. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI (1993) Continuous c-fos expression precedes programmed cell death in vivo. Nature 363:166-169
69. 69. Ginsberg D, Mechta F, Yaniv M, Oren M (1991) Wild-type p53 can down-modulate the activity of various promotors. Proc Natl Acad Sci. USA 88:9979-9983
70. 70. Santhanam U, Ray A, Seghal PB (1991) Repression of the interleukin 6 gene promotor by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 88: 7605-7609
71. 71. Shiio Y, Yamamoto T, Ymaguchi N (1992) Negative regulation of Rb expression by the p53 gene product. Proc Natl Acad Sci USA 89:5206-5210
72. 72. Subler M, Martin D, Deb S (1992) Inhibition of viral and cellular promotors by wild-type p53. J Virol 66:4757-4762
73. 73. Mack DH, Vartikar J, Pipas JM, Laimins LA (1993) Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363:281-283
74. 74. Shen Y, Shenk T (1994) Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc Natl Acad Sci USA 91:8940-8944
75. 75. Sabbatini P, Chiou SK, Rao L, White E (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol Cell Biol 15:1060-1070
76. 76. Maheswaran S, Englert C, Bennet P, Heinrich G, Haber DA (1995) The WT1 gene product stabilises p53 and inhibits p53-mediated apoptosis. Genes Dev 9:2143-2156
77. 77. Murphy M, Hinman A, Levine AJ (1996) Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev 10:2971-2980
78. WAF-1 and results in apoptosis and tumor suppression. Nat Med 4: 835-838
79. 79. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly J-M, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K, Harris C (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Gen 10:188-195
80. 80. Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, Xu G, Elmore L, Yeh H, Hoeijmakers JHJ, Harris C (1996) The XPB and XPD helicases are components of the p53-mediated apoptosis pathway. Genes Dev 10:1219-1232
81. 81. Lu H, Fisher RP, Bailey P, Levine AJ (1997) The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro. Mol Cell Biol 17:5923-5934
82. 82. Ko LJ, Shieh SY, Chen X, Jayaraman L, Tamai K, Taya Y, Prives C, Pan ZQ (1997) p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol Cell Biol 17:7220-7229
83. 83. Thornberry NA, Lazebik Y (1998) Caspases: enemies within. Science 281:1312-1316
84. 84. Gottlieb E, Oren M (1998) p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J 17:3587-3596
85. 85. Ding HF, McGill G, Rowan S, Schmaltz C, Shimamura A, Fisher DE (1998) Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J Biol Chem 273:28378-28383
86. 86. Bennett M, Macdonald K, Chan S-W, Luzio JP, Simari R, Weissberg P (1998) Cell surface trafficking of fas: a rapid mechanism of p53-mediated apoptosis. Science 282:290-293
87. 87. Chen X, Ko LJ, Jayaraman L, Prives C (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438-2451
88. 88. Theis S, Atz J, Mueller LN, Roemer K (1997) A function in apoptosis other than transactivation inherent in the NH2-terminal domain of p53. Int J Cancer 71:858-866
89. 89. Almog N, Li R, Peled A, Schwartz D, Wolkowicz R, Goldfinger N, Pei H, Rotter V (1997) The murine C′-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells. Mol Cell Biol 17:713-722
90. 90. Zhu J, Zhou W, Jiang J, Chen X (1998) Identification of a novel p53 functional domain that is necessary for mediating apoptosis. J Biol Chem 273:13030-13036
91. 91. Prives C (1998) Signaling to p53: Breaking the MDM2-p53 circuit. Cell 95:5-8
92. 92. Kapoor M, Lozano G (1998) Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc Natl Acad Sci USA 95:2834-2837
93. 93. Lu H, Taya Y, Ikeda M, Levine AJ (1998) Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc Natl Acad Sci USA 95:6399-6402
94. 94. Ronen D, Schwartz D, Teitz Y, Goldfinger N, Rotter V (1996) Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ 7:21-30
95. 95. Rotman G, Shiloh Y (1998) ATM: from gene to function. Hum Mol Genet 7:1555-1563
96. 96. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 11:3471-3481
97. 97. Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677
98. 98. Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siciliano JD (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679
99. 99. Waterman MJ, Stavridi ES, Waterman JL, Halazonetis TD (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet 19:175-178
100. 100. Barlow C, Brown KD, Deng CX, Tagle DA, Wynshaw-Boris A (1997) ATM selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat Genet 17:453-456
101. 101. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ (1998) Requirement for ATM in ionizing radiation-induced cell death in the developing central nervous system. Science 280:1089-1091
102. 102. Evan G, Littlewood T (1998) A matter of life and cell death. Science 281:1317-1322
103. 103. White AE, Livanos EM, Tlsty TD (1994) Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 8:666-677
104. 104. Reznikoff CA, Belair C, Savelieva E, Zhai Y, Pfeifer K, Yeager T, Thompson KJ, DeVries S, Bindley C, Newton MA, et al (1994) Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. Genes Dev 8:2227-2240
105. 105. Lowe SW, Ruley HE (1993) Stabilisation of the p53 tumor suppressor is induced by adenovirus 5 EIA and accompanies apoptosis. Genes Dev 7:535-545
106. 106. Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albert DM, Windle JJ (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8:1300-1310
107. 107. Pan H, Griep AE (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev 8:1285-1299
108. 108. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967
109. 109. Lowe SW, Jacks T, Housman DE, Ruley HE (1994) Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 91:2026-2030
110. 110. Morgenbesser SD, Williams BO, Jacks T, DePinho RA (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-74
111. kip1 mediates apoptosis in endothelial cells through activation of cdk2: role of a caspase cascade. Mol Cell 1:553-563
112. 112. Palmero I, Pantoja C, Serrano M (1998) p19ARF links the tumor suppressor p53 to ras. Nature 395:125-126
113. 113. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalisation. Genes Dev 12:2424-2433
114. 114. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW (1998) E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev 12:2434-2342
115. 115. Bates S, Phillips AC, Clarke PA, Stott F, Peters G, Ludwig RL, Vousden KH (1998) p14ARF links the tumor suppressors Rb and p53. Nature 395:124-125
116. 116. Kamijo T, Weber JD, Zambetti G, Zindy E, Roussel MF, Sherr CJ (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci USA 95:8292-8297
117. 117. Pomerantz J, Schreiber AN, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon CC, DePinho RA (1998) The Ink4a tumor suppressor gene product, p19ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713-723
118. 118. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G (1998) The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17:5001-5014
119. 119. Zhang Y, Xiong Y, Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734
120. 120. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649-659
121. 121. Symonds H, Krall L, Remington L, Saenz RM, Lowe S, Jacks T, Van DT (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-711
122. 122. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M, Vousden KH (1996) Specific loss of apoptotic but not cell cycle arrest function in a human tumor derived mutant p53. EMBO J 15:827-838